Lenka Fedorkova, Ph.D.
Download
1 / 17

Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs - PowerPoint PPT Presentation


  • 106 Views
  • Uploaded on

Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs. CEO Roundtable : Technical Assistance Programs. National Institutes of Health. Mt. “FDA” ???. NIH Technical Assistance Programs. Niche Assessment Program. Commercialization Assistance Program. Phase I. Phase II.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Lenka Fedorkova, Ph.D. Assistant Manager NIH SBIR/STTR Programs' - dante-martinez


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Lenka Fedorkova, Ph.D.

Assistant Manager

NIH SBIR/STTR Programs

CEO Roundtable:

Technical Assistance Programs

National Institutes of Health


Mt. “FDA”

???

NIH Technical Assistance Programs

Niche Assessment Program

Commercialization Assistance Program

Phase I

Phase II

Phase III

“Valley of Death”


Nih awardee needs
NIH Awardee Needs

  • Investment = Cash Flow “Valley of Death”

  • Market Validation = who will buy your product or pay for your service?

  • Defining Your Customer – Is your technology a “needed” solution to a defined problem?

  • Penetrating well-established/ crowded markets = Who is your competition versus strategic partner?

  • Protecting Intellectual Property = your “worth”


Niche assessment program

Technology Niche Analysis

Report helps Phase II submissions:

Identify other uses of technology

Determines competitive advantages

Market size and potential

Barriers to entry & strategy

Feedback from potential end-users

Phase I SBIR/STTR awardees

With current or soon to be awarded Phase I (Notice of Award)

Niche Assessment Program


Commercialization assistance program cap
Commercialization Assistance Program (CAP)

  • Personalized Business Mentoring; Knowledge Transfer; Business Outcomes!

  • Business & strategic planning

  • Investor & partnership pitch

  • Technology Value Proposition

  • FDA regulatory requirements

  • IP & Licensing Issues

  • Market Readiness

Phase II SBIR/STTR awardees

Active or 5 years since completion of project


Nih cap participants 2004 2013
NIH-CAP PARTICIPANTS: 2004-2013

Biotechnology

116 Companies

Other*

142 Companies

Diagnostics

97 Companies

Pharmaceuticals

89 Companies

Healthcare IT

99 Companies

Medical Devices

215 Companies

*Includes Clinical Research, Instrumentation, Research Tools


How cap works
How CAP Works

  • Customized Approach

    • Commercialization Training Track

    • Accelerated Commercialization Track

    • Regulatory Training Track

  • High-level industry and commercial expertise

    • Live feedback from active industry contacts

    • Mediated connections to industry partners and investors

  • High-quality workshops and events

  • Nationwide network of resources, referrals


The impact
The Impact

  • How do we measure SUCCESS?

    • Met with or closed deals with investors

    • Met with the FDA or obtained approval

    • Launched a product

    • Achieved revenue

    • Signed licensing agreements

    • Hired new employees

    • Established partnerships

    • Signed CDA


Nih cap results 2004 2012
NIH-CAP RESULTS: 2004-2012

  • Deals: Signed legal documents committing partners to a process, timeframe and outcome, including.:

  • Acquisitions

  • Distribution Agreements

  • Investment

  • - Licensing Agreements

  • - Technical Collaborations


Why nih cap matters

Strategic Introductions

Acquisitions

New Jobs Created

Millions Raised

WHY NIH-CAP MATTERS!

27

$586+

Results directly attributed by the companies to their participation in CAP

1,680+

4,400+


Get Connected

  • NIH Guide for Grants and Contracts (weekly notification)

    http://grants.nih.gov/grants/guide/listserv.htm

  • NIH SBIR/STTR Notification

  • Email [email protected] with ‘subscribe SBIR-STTR your name’

    in the message body:

  • Follow us on Twitter: @NIHsbir

  • Submit your SBIR/STTR Success Story at our Website: http://nih.sbir.gov



InvivoSciences, Inc.

  • Provides phenotypic compound screening services for first-in-class drug discovery and drug repositioning

  • Madison, WI

Ayla Annac, MBACo-Founder& CEO

  • http://www.invivosciences.com/


SenesTech, Inc.

  • Revolutionary technology for animal pest control that targets the heart of the problem: Reproduction

  • Flagstaff, AZ

  • http://senestech.com/

Loretta Mayer, Ph.D.

Founder & CEO


Actuated Medical, Inc.

  • Designs and develops next-generation, FDA-compliant medical devices

  • Bellefonte, PA

Maureen Mulvihill, Ph.D.

Co-Founder & CEO

  • http://www.actuatedmedical.com/


Biopsy Sciences, LLC.

  • A medical device company best known for their lead products, the BioSEAL and the HydroMARK

  • Clearwater, FL

  • http://www.hydromark.com/

John Fisher, M.D.

Founder & CEO


Learn More at

sbir.nih.gov/tap


ad